FourThought Financial’s Zimmer Biomet ZBH Stock Holding History

FourThought Financial’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$63K	Buy	606 +1	+0.2%	+$110	0.01%	536
2022 Q2	$64K	Buy	605 +23	+4%	+$2.73K	0.01%	542
2022 Q1	$74K	Sell	582 -17	-3%	-$2.05K	0.01%	553
2021 Q4	$74K	Hold	599	–	–	0.01%	555
2021 Q3	$85K	Hold	599	–	–	0.01%	531
2021 Q2	$93K	Hold	599	–	–	0.01%	525
2021 Q1	$93K	Sell	599 -11	-2%	-$1.7K	0.01%	511
2020 Q4	$91K	Buy	+610	New	+$86.2K	0.01%	507

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FourThought Financial's ZBH Position: Q3 2022 in Review

FourThought Financial increased its Zimmer Biomet (ZBH) stake by 0.17% in Q3 2022, buying an estimated $110 and bringing the position to 606 shares worth $63K. The position accounts for 0.01% of the portfolio, ranked #536.

FourThought Financial first reported a position in ZBH in Q4 2020 and has held it in 8 quarters since. The position peaked at $93K in Q2 2021. 920 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

FourThought Financial held 606 shares of Zimmer Biomet worth $63K as of Q3 2022.
FourThought Financial bought 1 Zimmer Biomet share in Q3 2022, an estimated $110.
Zimmer Biomet made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #536 holding.
FourThought Financial first reported a position in Zimmer Biomet in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Zimmer Biomet position peaked at $93K in Q2 2021.
920 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.